Cabotegravir bests TDF-FTC for HIV prevention in those at risk
(HealthDay)—For men who have sex with men (MSM) and transgender women, long-acting injectable cabotegravir (CAB-LA, an integrase strand-transfer inhibitor [INSTI]) is superior to tenofovir disoproxil fumarate-emtricitabine ...
Aug 12, 2021
0
143